JP2024532131A5 - - Google Patents
Info
- Publication number
- JP2024532131A5 JP2024532131A5 JP2024509042A JP2024509042A JP2024532131A5 JP 2024532131 A5 JP2024532131 A5 JP 2024532131A5 JP 2024509042 A JP2024509042 A JP 2024509042A JP 2024509042 A JP2024509042 A JP 2024509042A JP 2024532131 A5 JP2024532131 A5 JP 2024532131A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- subject
- item
- pharmaceutical composition
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (25)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163234176P | 2021-08-17 | 2021-08-17 | |
| US63/234,176 | 2021-08-17 | ||
| US202163235098P | 2021-08-19 | 2021-08-19 | |
| US63/235,098 | 2021-08-19 | ||
| US202163237120P | 2021-08-25 | 2021-08-25 | |
| US202163237089P | 2021-08-25 | 2021-08-25 | |
| US63/237,089 | 2021-08-25 | ||
| US63/237,120 | 2021-08-25 | ||
| US202163237506P | 2021-08-26 | 2021-08-26 | |
| US63/237,506 | 2021-08-26 | ||
| US202163270421P | 2021-10-21 | 2021-10-21 | |
| US63/270,421 | 2021-10-21 | ||
| US202163281994P | 2021-11-22 | 2021-11-22 | |
| US63/281,994 | 2021-11-22 | ||
| US202163290599P | 2021-12-16 | 2021-12-16 | |
| US63/290,599 | 2021-12-16 | ||
| US202163294715P | 2021-12-29 | 2021-12-29 | |
| US63/294,715 | 2021-12-29 | ||
| US202263322155P | 2022-03-21 | 2022-03-21 | |
| US63/322,155 | 2022-03-21 | ||
| US202263339307P | 2022-05-06 | 2022-05-06 | |
| US63/339,307 | 2022-05-06 | ||
| US202263353790P | 2022-06-20 | 2022-06-20 | |
| US63/353,790 | 2022-06-20 | ||
| PCT/US2022/040663 WO2023023199A1 (en) | 2021-08-17 | 2022-08-17 | Methods of treating copper metabolism-associated diseases or disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532131A JP2024532131A (ja) | 2024-09-05 |
| JP2024532131A5 true JP2024532131A5 (https=) | 2025-08-26 |
Family
ID=83271296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509042A Pending JP2024532131A (ja) | 2021-08-17 | 2022-08-17 | 銅代謝関連疾患又は障害を治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250082674A1 (https=) |
| EP (1) | EP4387631A1 (https=) |
| JP (1) | JP2024532131A (https=) |
| CA (1) | CA3228221A1 (https=) |
| WO (1) | WO2023023199A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023038909A1 (en) * | 2021-09-07 | 2023-03-16 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
| KR20240159714A (ko) * | 2023-04-27 | 2024-11-06 | 국립해양생물자원관 | 다중구리 산화효소 활성 도메인의 개량 펩타이드를 포함하는 구리대사 관련 신경계 질환의 예방 또는 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11419832B2 (en) * | 2017-12-04 | 2022-08-23 | Alexion Pharmaceuticals, Inc. | Bis-choline tetrathiomolybdate for treating Wilson Disease |
| MX2020006284A (es) * | 2017-12-04 | 2021-04-12 | Alexion Pharma Int Operations Unlimited Company | Tetratiomolibdato de bis-colina para tratar la enfermedad de wilson. |
| US20220334135A1 (en) | 2019-09-12 | 2022-10-20 | Alexion Pharmaceuticals, Inc. | Methods of measuring copper concentration in biological samples |
| US20220387370A1 (en) * | 2019-11-21 | 2022-12-08 | Alexion Pharmaceuticals, Inc. | Methods of reducing neurological damage in wilson disease patients |
| EP4243806A1 (en) * | 2020-11-13 | 2023-09-20 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
| WO2023038909A1 (en) * | 2021-09-07 | 2023-03-16 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
-
2022
- 2022-08-17 WO PCT/US2022/040663 patent/WO2023023199A1/en not_active Ceased
- 2022-08-17 US US18/292,042 patent/US20250082674A1/en active Pending
- 2022-08-17 CA CA3228221A patent/CA3228221A1/en active Pending
- 2022-08-17 JP JP2024509042A patent/JP2024532131A/ja active Pending
- 2022-08-17 EP EP22768535.1A patent/EP4387631A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI280136B (en) | Composition containing dipeptide of histidine and alanine for reducing uric acid | |
| JP2024532131A5 (https=) | ||
| JP2015028042A (ja) | 抗ｉｌ−５抗体を投与するための方法 | |
| JP2022515480A5 (https=) | ||
| JPS63502591A (ja) | リユ−マチ様関節炎の治療のための方法と物質 | |
| AU2021200093B2 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| CN119095617A (zh) | 用于治疗患有头皮斑块型银屑病的受试者的方法 | |
| JP2023541048A (ja) | パーキンソン病の処置 | |
| CN120500294A (zh) | 抗trem2抗体和其用途 | |
| CN115397849A (zh) | 减少患有认知衰退的患者中的β-淀粉样蛋白单体水平的方法 | |
| US20230391859A1 (en) | Anti-transthyretin antibodies and methods of use thereof | |
| JP2023549814A5 (https=) | ||
| JP2024540641A (ja) | 抗ｔｒｅｍ２抗体及びその使用 | |
| JP2024534936A5 (https=) | ||
| EP3137094A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| EA007097B1 (ru) | Способ взаимодействия алкалоидов и применение продуктов реакции в получении лекарственных средств | |
| US20150297591A1 (en) | Methods of treating pulmonary fibrosis | |
| WO2015165966A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| US11793775B2 (en) | Combined therapy for treating Alzheimer's disease | |
| WO2016189491A1 (en) | Novel formulation | |
| US11382925B2 (en) | Agent for treating retinal disease | |
| CN118900846A (zh) | 抗trem2抗体及其用途 | |
| WO2015165971A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| TW202430217A (zh) | 用於免疫介導之壞死性肌病變之治療及預防的抗ｃｄ１９結合劑 | |
| Hasselgren et al. | Pharmacokinetics of esomeprazole are not affected by age: an assessment in the elderly |